Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Taiwan · Delayed Price · Currency is TWD

64.50

+0.20 (0.31%)

Jul 16, 2026, 1:30 PM CST

13.76% (1Y)

Market Cap	11.49B +11.8%
Revenue (ttm)	7.03B +3.2%
Net Income	964.51M +17.3%
EPS	5.38 +17.0%
Shares Out	178.70M
PE Ratio	11.95
Forward PE	n/a
Dividend	2.00 (3.13%)
Ex-Dividend Date	Jul 23, 2026

Volume	177,211
Open	64.30
Previous Close	64.30
Day's Range	63.80 - 64.50
52-Week Range	53.50 - 66.60
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company o... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1967

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1720

Full Company Profile

Financial Performance

In 2025, TPE:1720's revenue was 7.02 billion, an increase of 3.44% compared to the previous year's 6.79 billion. Earnings were 927.66 million, an increase of 5.36%.

Financial Statements